000503.SZ
000503.SZ
CNE000000255
CHINA REFORM HEALTH
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 60/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±50.8% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).

Beta (Market Relation)
0.48x
Defensive
Volatility (5Y p.a.)
50.8% p.a.
5-Year Horizon
Max Drawdown (5Y)
-71.4%
5-Year Horizon
Sharpe Ratio
0.04
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -17.8%
3 Years 48.8% -63.2% -0.21 -7.5%
5 Years 50.8% -71.4% 0.04 +4.1%
10 Years 49.9% -89.9% -0.37 -15.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (50.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -89.9% in the extended horizon.
ende